Association of HIV infection with distribution and viral load of HPV types in Kenya: A survey with 820 female sex workers

BMC Infectious Diseases

Volumn 10, Issue , 2010, Pages

  Luchters, Stanley M F ^a,b   Broeck, Davy V ^a,b   Chersich, Matthew F ^b,c   Nel, Annalene ^d   Delva, Wim ^b,h   Mandaliya, Kishor ^e   Depuydt, Christophe E ^f,g  

^a International Centre for Reproductive Health Kenya   (Kenya)

^b GHENT UNIVERSITY   (Belgium)

^c UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^d INTERNATIONAL PARTNERSHIP FOR MICROBICIDES   (United States)

^e Department of Obstetrics and Gynaecology   (Kenya)

^f UNIVERSITY OF ANTWERP   (Belgium)

^g Laboratory for clinical pathology (Labo Lokeren Campus Riatol)   (Belgium)

^h STELLENBOSCH UNIVERSITY   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

WART VIRUS VACCINE;

ADULT; AGE; ARTICLE; BLOOD SAMPLING; CONDOM; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; FEMALE; FEMALE WORKER; GYNECOLOGICAL EXAMINATION; HEALTH SURVEY; HIGH RISK PATIENT; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; INTERVIEW; KENYA; MAJOR CLINICAL STUDY; PAPANICOLAOU TEST; PAPILLOMAVIRUS INFECTION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SEX WORKER; SEXUAL BEHAVIOR; SOCIOECONOMICS; SPECIES DISTRIBUTION; UTERINE CERVIX CYTOLOGY; VIRUS LOAD; VIRUS TYPING; ADOLESCENT; CLASSIFICATION; COMORBIDITY; GENETICS; ISOLATION AND PURIFICATION; MIDDLE AGED; PAPILLOMA VIRUS; PATHOLOGY; PREVALENCE; PROSTITUTION; UTERINE CERVIX; UTERINE CERVIX TUMOR; VIROLOGY;

ADOLESCENT; ADULT; CERVIX UTERI; COMORBIDITY; CROSS-SECTIONAL STUDIES; FEMALE; HIV INFECTIONS; HUMANS; KENYA; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PREVALENCE; PROSTITUTION; UTERINE CERVICAL NEOPLASMS; VIRAL LOAD; YOUNG ADULT;

EID: 77649317287     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-10-18     Document Type: Article

References (55)

1. Parkin DM, Bray F. Chapter 2: The burden of HPV-related cancers. Vaccine 2006, 24(Suppl 3):S11-25.
2. International Agency for Research on Cancer Human papillomaviruses. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans 2006, 90. International Agency for Research on Cancer.
3. de Villiers EM, Fauquet C, Broker TR, Bernard HU, zur Hausen H. Classification of papillomaviruses. Virology 2004, 324(1):17-27. 10.1016/j.virol.2004.03.033, 15183049.
4. Bouvard V, Baan R, Straif K, Grosse Y, Secretan B, El Ghissassi F, Benbrahim-Tallaa L, Guha N, Freeman C, Galichet L, et al. A review of human carcinogens--Part B: biological agents. Lancet Oncol 2009, 10(4):321-322. 10.1016/S1470-2045(09)70096-8, 19350698.
5. McClelland RS, Ndinya-Achola JO, Baeten JM. Re: distinguishing the temporal association between women's intravaginal practices and risk of human immunodeficiency virus infection: a prospective study of South African women. Am J Epidemiol 2007, 165(4):474-475. author reply 475-476, 10.1093/aje/kwk101, 17158477.
6. del Amo J, Gonzalez C, Losana J, Clavo P, Munoz L, Ballesteros J, Garcia-Saiz A, Belza MJ, Ortiz M, Menendez B, et al. Influence of age and geographical origin in the prevalence of high risk human papillomavirus in migrant female sex workers in Spain. Sex Transm Infect 2005, 81(1):79-84. 10.1136/sti.2003.008060, 1763723, 15681729.
7. Chatterjee R, Mukhopadhyay D, Murmu N, Jana S. Prevalence of human papillomavirus infection among prostitutes in Calcutta. J Environ Pathol Toxicol Oncol 2001, 20(2):113-117.
8. Ishi K, Suzuki F, Saito A, Kubota T. Prevalence of human papillomavirus infection and its correlation with cervical lesions in commercial-sex workers in Japan. J Obstet Gynaecol Res 2000, 26(4):253-257.
9. Strickler HD, Burk RD, Fazzari M, Anastos K, Minkoff H, Massad LS, Hall C, Bacon M, Levine AM, Watts DH, et al. Natural history and possible reactivation of human papillomavirus in human immunodeficiency virus-positive women. J Natl Cancer Inst 2005, 97(8):577-586.
10. De Vuyst H, Lillo F, Broutet N, Smith JS. HIV, human papillomavirus, and cervical neoplasia and cancer in the era of highly active antiretroviral therapy. Eur J Cancer Prev 2008, 17(6):545-554. 10.1097/CEJ.0b013e3282f75ea1, 18941376.
11. Mandelblatt JS, Kanetsky P, Eggert L, Gold K. Is HIV infection a cofactor for cervical squamous cell neoplasia?. Cancer Epidemiol Biomarkers Prev 1999, 8(1):97-106.
12. Wallin KL, Wiklund F, Angstrom T, Bergman F, Stendahl U, Wadell G, Hallmans G, Dillner J. Type-specific persistence of human papillomavirus DNA before the development of invasive cervical cancer. N Engl J Med 1999, 341(22):1633-1638. 10.1056/NEJM199911253412201, 10572150.
13. Palefsky JM. Cervical human papillomavirus infection and cervical intraepithelial neoplasia in women positive for human immunodeficiency virus in the era of highly active antiretroviral therapy. Curr Opin Oncol 2003, 15(5):382-388. 10.1097/00001622-200309000-00007, 12960521.
14. Dunkle KL, Jewkes RK, Brown HC, Gray GE, McIntryre JA, Harlow SD. Transactional sex among women in Soweto, South Africa: prevalence, risk factors and association with HIV infection. Soc Sci Med 2004, 59(8):1581-1592. 10.1016/j.socscimed.2004.02.003, 15279917.
15. Yeoh GP, Tse MP, Chan KW, Lord L. Human papillomavirus DNA and liquid-based cervical cytology cotesting in screening and follow-up patient groups. Acta Cytol 2006, 50(6):627-631.
16. Kirungi WL, Musinguzi J, Madraa E, Mulumba N, Callejja T, Ghys P, Bessinger R. Trends in antenatal HIV prevalence in urban Uganda associated with uptake of preventive sexual behaviour. Sex Transm Infect 2006, 82(Suppl 1):i36-41. 10.1136/sti.2005.017111, 2593075, 16581758.
17. Chin-Hong PV, Husnik M, Cranston RD, Colfax G, Buchbinder S, Da Costa M, Darragh T, Jones D, Judson F, Koblin B, et al. Anal human papillomavirus infection is associated with HIV acquisition in men who have sex with men. AIDS 2009, 23(9):1135-1142. 10.1097/QAD.0b013e32832b4449, 19390418.
18. Auvert B, Lissouba P, Cutler E, Zarca K, Puren A, Taljaard D. Is genital human papillomavirus infection associated with HIV incidence?. 5th IAS conference on HIV pathogenesis, treatment and prevention: 2009; Cape Town, South Africa 2009,
19. Smith JC, Moses S, Hudgens M, Parker CB, Agot K, Maclean I, Ndinya-Achola JO, Snijders PJF, Meijer CJLM, Bailey RC. Risk of HIV acquisition among men with and without human papillomavirus infection in Kisumu, Kenya. 5th IAS conference on HIV pathogenesis, treatment and prevention 2009; Cape Town, South Africa 2009,
20. WHO Human papillomavirus and HPV vaccines: technical information for policy-makers and health professionals. 2007, WHO.
21. WHO Global Immunization Data. 2009, WHO., http://www.who.int/immunization/newsroom/GID_english.pdf
22. Hawken MP, Melis RD, Ngombo DT, Mandaliya K, Ng'ang'a LW, Price J, Dallabetta G, Temmerman M. Part time female sex workers in a suburban community in Kenya: a vulnerable hidden population. Sex Transm Infect 2002, 78(4):271-273. 10.1136/sti.78.4.271, 1744494, 12181465.
23. Luchters S, Chersich MF, Rinyiru A, Barasa MS, King'ola N, Mandaliya K, Bosire W, Wambugu S, Mwarogo P, Temmerman M. Impact of five years of peer-mediated interventions on sexual behavior and sexually transmitted infections among female sex workers in Mombasa, Kenya. BMC Public Health 2008, 8:143. 10.1186/1471-2458-8-143, 2397398, 18445258.
24. Ulin PR, Robinson E, Tolley EE. Qualitative methods in public health: a field guide for applied research. 2005, Published by Jossey-Bass.
25. Davey DD. Cervical cytology classification and the Bethesda System. Cancer J 2003, 9(5):327-334. 10.1097/00130404-200309000-00002, 14690307.
26. Depuydt CE, Benoy IH, Bailleul EJ, Vandepitte J, Vereecken AJ, Bogers JJ. Improved endocervical sampling and HPV viral load detection by Cervex-Brush Combi. Cytopathology 2006, 17(6):374-381. 10.1111/j.1365-2303.2006.00386.x, 17168921.
27. Armitage B, Berry G, Matthews JNS. Statistical methods in medical research. 2002, Blackwell publishing.
28. Clifford GM, Goncalves MA, Franceschi S. Human papillomavirus types among women infected with HIV: a meta-analysis. AIDS 2006, 20(18):2337-2344. 10.1097/01.aids.0000253361.63578.14, 17117020.
29. Ng'andwe C, Lowe JJ, Richards PJ, Hause L, Wood C, Angeletti PC. The distribution of sexually-transmitted Human Papillomaviruses in HIV positive and negative patients in Zambia, Africa. BMC Infect Dis 2007, 7:77. 10.1186/1471-2334-7-77, 1949816, 17634108.
30. Juarez-Figueroa LA, Wheeler CM, Uribe-Salas FJ, Conde-Glez CJ, Zampilpa-Mejia LG, Garcia-Cisneros S, Hernandez-Avila M. Human papillomavirus: a highly prevalent sexually transmitted disease agent among female sex workers from Mexico City. Sex Transm Dis 2001, 28(3):125-130. 10.1097/00007435-200103000-00001, 11289192.
31. Chaturvedi AK, Myers L, Hammons AF, Clark RA, Dunlap K, Kissinger PJ, Hagensee ME. Prevalence and clustering patterns of human papillomavirus genotypes in multiple infections. Cancer Epidemiol Biomarkers Prev 2005, 14(10):2439-2445. 10.1158/1055-9965.EPI-05-0465, 16214929.
32. Palefsky JM, Minkoff H, Kalish LA, Levine A, Sacks HS, Garcia P, Young M, Melnick S, Miotti P, Burk R. Cervicovaginal human papillomavirus infection in human immunodeficiency virus-1 (HIV)-positive and high-risk HIV-negative women. J Natl Cancer Inst 1999, 91(3):226-236. 10.1093/jnci/91.3.226, 10037100.
33. Levi JE, Fernandes S, Tateno AF, Motta E, Lima LP, Eluf-Neto J, Pannuti CS. Presence of multiple human papillomavirus types in cervical samples from HIV-infected women. Gynecol Oncol 2004, 92(1):225-231. 10.1016/j.ygyno.2003.10.004, 14751163.
34. Strickler HD, Palefsky JM, Shah KV, Anastos K, Klein RS, Minkoff H, Duerr A, Massad LS, Celentano DD, Hall C, et al. Human papillomavirus type 16 and immune status in human immunodeficiency virus-seropositive women. J Natl Cancer Inst 2003, 95(14):1062-1071.
35. Munoz N, Franceschi S, Bosetti C, Moreno V, Herrero R, Smith JS, Shah KV, Meijer CJ, Bosch FX. Role of parity and human papillomavirus in cervical cancer: the IARC multicentric case-control study. Lancet 2002, 359(9312):1093-1101. 10.1016/S0140-6736(02)08151-5, 11943256.
36. Munoz N, Bosch FX, de Sanjose S, Tafur L, Izarzugaza I, Gili M, Viladiu P, Navarro C, Martos C, Ascunce N, et al. The causal link between human papillomavirus and invasive cervical cancer: a population-based case-control study in Colombia and Spain. Int J Cancer 1992, 52(5):743-749. 10.1002/ijc.2910520513, 1330933.
37. Chersich MF, Luchters SM, Yard E, Othigo JM, Kley N, Temmerman M. Morbidity in the first year postpartum among HIV-infected women in Kenya. Int J Gynaecol Obstet 2008, 100(1):45-51. 10.1016/j.ijgo.2007.06.053, 17900585.
38. Temmerman M, Tyndall MW, Kidula N, Claeys P, Muchiri L, Quint W. Risk factors for human papillomavirus and cervical precancerous lesions, and the role of concurrent HIV-1 infection. Int J Gynaecol Obstet 1999, 65(2):171-181. 10.1016/S0020-7292(99)00043-0, 10405062.
39. Dal Maso L, Franceschi S, Polesel J, Braga C, Piselli P, Crocetti E, Falcini F, Guzzinati S, Zanetti R, Vercelli M, et al. Risk of cancer in persons with AIDS in Italy, 1985-1998. Br J Cancer 2003, 89(1):94-100. 10.1038/sj.bjc.6601017, 2394201, 12838307.
40. Clifford GM, Gallus S, Herrero R, Munoz N, Snijders PJ, Vaccarella S, Anh PT, Ferreccio C, Hieu NT, Matos E, et al. Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis. Lancet 2005, 366(9490):991-998. 10.1016/S0140-6736(05)67069-9, 16168781.
41. Odida M, de Sanjose S, Quint W, Bosch XF, Klaustermeier J, Weiderpass E. Human Papillomavirus type distribution in invasive cervical cancer in Uganda. BMC Infect Dis 2008, 8:85. 10.1186/1471-2334-8-85, 2459185, 18577214.
42. Dames DN, Ragin C, Griffith-Bowe A, Gomez P, Butler R. The prevalence of cervical cytology abnormalities and human papillomavirus in women infected with the human immunodeficiency virus. Infect Agent Cancer 2009, 4(Suppl 1):S8. 10.1186/1750-9378-4-S1-S8, 2638467, 19208213.
43. Burk RD, Kelly P, Feldman J, Bromberg J, Vermund SH, DeHovitz JA, Landesman SH. Declining prevalence of cervicovaginal human papillomavirus infection with age is independent of other risk factors. Sex Transm Dis 1996, 23(4):333-341.
44. Woodman CB, Collins S, Winter H, Bailey A, Ellis J, Prior P, Yates M, Rollason TP, Young LS. Natural history of cervical human papillomavirus infection in young women: a longitudinal cohort study. Lancet 2001, 357(9271):1831-1836. 10.1016/S0140-6736(00)04956-4, 11410191.
45. De Vuyst H, Clifford GM, Nascimento MC, Madeleine MM, Franceschi S. Prevalence and type distribution of human papillomavirus in carcinoma and intraepithelial neoplasia of the vulva, vagina and anus: a meta-analysis. Int J Cancer 2009, 124(7):1626-1636. 10.1002/ijc.24116, 19115209.
46. Fontaine J, Hankins C, Money D, Rachlis A, Pourreaux K, Ferenczy A, Coutlee F. Human papillomavirus type 16 (HPV-16) viral load and persistence of HPV-16 infection in women infected or at risk for HIV. J Clin Virol 2008, 43(3):307-312. 10.1016/j.jcv.2008.07.013, 18786854.
47. Clifford GM, Smith JS, Plummer M, Munoz N, Franceschi S. Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis. Br J Cancer 2003, 88(1):63-73. 10.1038/sj.bjc.6600688, 2376782, 12556961.
48. Munoz N, Bosch FX, de Sanjose S, Herrero R, Castellsague X, Shah KV, Snijders PJ, Meijer CJ. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003, 348(6):518-527. 10.1056/NEJMoa021641, 12571259.
49. De Carvalho NS. Cervical cancer vaccination: the real meaning of cross-protection and its impact on the prevention. Vaccine 2008, 26(50):6293-6294. 10.1016/j.vaccine.2008.09.001, 18804508.
50. De Vuyst H, Steyaert S, Van Renterghem L, Claeys P, Muchiri L, Sitati S, Vansteelandt S, Quint W, Kleter B, Van Marck E, et al. Distribution of human papillomavirus in a family planning population in nairobi, kenya. Sex Transm Dis 2003, 30(2):137-142. 10.1097/00007435-200302000-00009, 12567172.
51. Palefsky JM, Gillison ML, Strickler HD. Chapter 16: HPV vaccines in immunocompromised women and men. Vaccine 2006, 24(Suppl 3):S140-146.
52. Schulz KF, Grimes DA. Sample size slippages in randomised trials: exclusions and the lost and wayward. Lancet 2002, 359(9308):781-785. 10.1016/S0140-6736(02)07882-0, 11888606.
53. Smith JS, Lindsay L, Hoots B, Keys J, Franceschi S, Winer R, Clifford GM. Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update. Int J Cancer 2007, 121(3):621-632. 10.1002/ijc.22527, 17405118.
54. Thomsen SC, Ombidi W, Toroitich-Ruto C, Wong EL, Tucker HO, Homan R, Kingola N, Luchters S. A prospective study assessing the effects of introducing the female condom in a sex worker population in Mombasa, Kenya. Sex Transm Infect 2006, 82(5):397-402. 10.1136/sti.2006.019992, 2563858, 16854997.
55. Bosire W, Luchters S, Nel A, Malava E, Malonza I, Temmerman M. A prospective microbicides preparedness study for estimation of HIV-1 incidence among female sex workers in Mombasa, Kenya. Microbicides 2008: 2008; New Delhi, India 2008,